CPRX — CATALYST PHARMACEUTICALS INC

Ownership history in Advisory Services Network, LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 2,002 +1,502 +300.4% 0.00% $39K $19.70
2023 Q4 REDUCED 500 -1,301 -72.2% 0.00% $8K $16.81
2023 Q1 ADDED 1,801 +1,301 +260.2% 0.00% $30K $16.58
2022 Q4 ADDED 500 +100 +25.0% 0.00% $9K $18.60
2020 Q3 INITIATED 400 — — 0.00% $1K $2.97
% of Fund (quarterly)    CPRX price (monthly, adj. close)

Other funds also holding CPRX

As of 2025 Q4 — sorted by position size

TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 4.87% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.19% JW Asset Management, LLC 3Y 7Y 2.95% Knott David M Jr 3Y 2.04% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.46% QSV Equity Investors LLC 1.24% Bridge City Capital, LLC 3Y 7Y 1.07% GLOBEFLEX CAPITAL L P 3Y 7Y 1.04% JUNCTURE WEALTH STRATEGIES, LLC 3Y 7Y 0.65% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.6%
← Back to Advisory Services Network, LLC Holdings